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Abstract 
Despite the high clinical burden little is known about pathophysiology underlying autism spectrum 
disorder (ASD). Recent resting state functional magnetic resonance imaging (rs-fMRI) studies have 
found atypical synchronization of brain activity in ASD. However, no consensus has been reached on 
the nature and clinical relevance of these alterations. Here we addressed these questions in four large 
ASD cohorts. Using rs-fMRI we identified functional connectivity alterations associated with ASD. We 
tested for associations of these imaging phenotypes with clinical and demographic factors such as age, 
sex, medication status and clinical symptom severity. Our results showed reproducible patterns of ASD-
associated functional hyper- and hypo-connectivity.  Hypo-connectivity was primarily restricted to 
sensory-motor regions whereas hyper-connectivity hubs were predominately located in prefrontal and 
parietal cortices. Shifts in cortico-cortical between-network connectivity from outside to within the 
identified regions were shown to be a key driver of these abnormalities. This reproducible 
pathophysiological phenotype  was partially associated with core ASD symptoms related to 
communication and daily living skills and was not affected by age, sex or medication status. Whilst the 
large effect sizes in standardized cohorts are encouraging with respect to potential application as a 
treatment and for patient stratification, the moderate link to clinical symptoms and the large overlap 
with healthy controls currently limit the usability of identified alterations as diagnostic or efficacy read-
out.  
Overline: Autism spectrum disorder 
One sentence summary:  Functional connectivity alterations are conserved in multiple cohorts 
of patients with autism spectrum disorder.  
 
 
 
  
Holiga et al. 
Introduction 
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in 
social interaction and communication, and by the presence of restricted and stereotyped behaviors and 
sensory anomalies(1). ASD occurs in up to about 1% of general child population(2) and despite its 
early-childhood onset and lifelong persistence, little is known about the neurobiology underlying its 
cause and pathogenesis(3). Based on various divergent findings several theories have been proposed to 
explain ASD at genetic, neuropathology, systemic and behavioral levels(4, 5). On a systemic level, the 
hypothesis of abnormal brain functional connectivity has been proposed more than a decade ago(6). 
One of the prevailing experimental approaches to study brain functional connectivity non-
invasively is by resting-state functional magnetic resonance imaging (rs-fMRI) (7). Rs-fMRI reflects 
spontaneous neuronal activity by detecting slow fluctuations of local oxygen demands (8). Inter-
regional temporal synchronization of the intrinsic hemodynamics is then considered as an index of 
functional connectivity(8). A significant body of evidence now supports the existence of such functional 
connectivity alterations in ASD(9–15) and correlation of such alterations with autistic traits in 
neurotypical populations(16). However, the field has still failed to converge on the anatomy, nature, 
directionality and clinical relevance of the observed alterations. Whereas some reports point to an hypo-
connectivity phenotype(17–19), others reported hyper-connectivity(12, 20), and some observed a mix 
of both phenomena(10, 21). Besides inherent disease heterogeneity, this discordance has been proposed 
to arise from age or methodological differences between studies(19, 22, 23), or failures to account for 
medication effects in the analyses(24). Yet other works highlight the importance of spatial variability 
in connectivity as a key source of heterogeneity in ASD(21, 25). A common caveat in interpretation of 
these studies is the lack of replication of respective findings. A consensus on the nature and clinical 
relevance of the functional connectivity changes in ASD therefore still needs to be reached. These 
uncertainties limit the usability of functional connectivity as a potential diagnostic or treatment 
biomarker for ASD. 
Here we aimed to address these inconsistent findings by performing a large-scale evaluation and 
characterization of functional connectivity alterations in ASD in four independent cohorts. More 
specifically, we used the EU-AIMS LEAP (European Autism Interventions - A Multicentre Study for 
Developing New Medications – EU-AIMS, Longitudinal European Autism Project – LEAP) dataset for 
exploration and the other three cohorts (ABIDE (Autism Brain Imaging Data Exchange) I, ABIDE II 
and InFoR (Inserm, la Fondation FondaMental et Roche)) for replication. We further evaluated the link 
between these alterations and age, medication status and clinical symptoms. 
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Results 
Clinical and demographic characteristics are comparable between patients with ASD and 
typically developing volunteers (TD)  
Rs-fMRI data from four ASD cohorts (EU-AIMS LEAP, ABIDE I, ABIDE II and InFoR) alongside 
with matched TD  were included in the study (Table 1). The multi-center EU-AIMS LEAP and the 
single center InFoR are prospective cohorts providing standardized rs-fMRI data alongside with various 
clinical parameters. ABIDE I and II represent large-scale retrospectively aggregated datasets provided 
by international brain imaging centers. Exclusion of individuals with low IQ and removal of poor image 
quality data resulted in exclusion of 35, 39, 33 and 14% of available EU-AIMS LEAP, ABIDE I, 
ABIDE II and InFoR data, respectively (Table 1 for final number of subjects (N)). For all cohorts, mean 
age did not differ between individuals with ASD and TD and was comparable between EU-AIMS LEAP 
and ABIDE I (Table 1). ABIDE II cohort was significantly younger (all p<.001) and the InFoR only 
comprised adult individuals with ASD. A significantly higher fraction of males was observed in the 
ABIDE I and II as compared to EU-AIMS LEAP (ABIDE I: p<0.001, ABIDE II: p=0.005) and InFoR 
(for ABIDE I only: p=0.042). Individuals with ASD in all cohorts had average IQ above 100 although 
lower than that for TD in all cohorts except InFoR (EU-AIMS LEAP: p=0.033, ABIDE I and II: 
p<0.001, InFoR: p=0.392, Table 1).  
Reproducible degree centrality alterations are observed in individuals with ASD 
To test for functional connectivity differences between individuals with ASD and TD, we used the EU-
AIMS LEAP dataset for exploratory analyses and the other three cohorts for replication. Degree 
centrality (DC) was chosen as an unbiased count-based functional connectivity measure that assigns to 
each voxel the sum of all correlation coefficients between the time series of that voxel and all other 
voxels in the brain exceeding a prespecified threshold. Group comparisons in the EU-AIMS cohort 
revealed significant DC increases in individuals with ASD in two clusters comprising bilateral parietal 
(p=0.008), prefrontal and anterior and posterior cingulate regions (p=0.001) (Fig 1A and Table 2 ). 
Significantly decreased DC was observed in a cluster covering bilateral primary sensory motor cortices 
and right temporal regions, insula, amygdala and hippocampus (p<0.001) (Fig 1A). These results 
remained qualitatively and quantitatively similar to the initial findings after controlling for between-
subject differences in motion (fig. S1, table S1). 
DC extracted from ABIDE I, ABIDE II and InFoR based on the EU-AIMS LEAP DC increase mask 
revealed significant increases in individuals with ASD in all three replication cohorts in the same areas 
showing increased connectivity in the exploratory cohort (ABIDE I: p=0.011, ABIDE II: p=0.01, 
InFoR: p<0.001, Fig 1B). Conversely, the DC decreases were successfully replicated in two out of three 
cohorts (ABIDE I: p=0.001, InFoR: p=0.002) (Fig 1B). We further evaluated the spatial similarity of 
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the unthresholded DC alteration patterns by computing correlation coefficients between voxel-wise t-
maps obtained for each cohort in the comparisons of ASD and TD (Fig 1C). These analyses revealed 
significant correlations of the ASD profiles across all four cohorts (all p<0.001, Fig 1D). 
Degree centrality alterations in ASD are driven by shifts in connectivity 
Having identified replicable DC alterations in individuals with ASD we aimed to explore the nature of 
these connectivity differences. To this end, we compared the whole-brain histograms of correlation 
coefficients observed in individuals with ASD to TD revealing a nearly identical distribution of 
correlation strength (Fig 2A). We next computed effect sizes for differentiation between individuals 
with ASD and TD for four types of metrics comparing means, variances, proportions and shifts in 
connectivity within, outside and from within to outside the identified DC alteration clusters (fig. S2). 
These analyses revealed that shifts in correlations from outside to inside the DC increase mask showed 
the largest effect size (Fig 2B). This large effect reflects that in ASD voxels falling outside the DC 
increase mask show reduced connectivity to one another and an increased connectivity to voxels within 
the mask. This hyper-connectivity index was closely negatively correlated with the initial DC finding 
(r=-0.72; p<0.001; N=394) (fig. S3). Additionally, reduced overall connectivity and reduced proportion 
of connected voxels were observed within the DC increase mask and an increased variance of 
connections outside the respective mask (Fig 2B). 
For the DC decrease findings, three indices revealed similar effect size as the initial DC finding: reduced 
mean connectivity and number of connected voxels within the DC decrease mask, and shift in 
connectivity from outside to inside the DC decrease mask (Fig 2B). For the latter, the proportion of 
voxels connected to each other outside the DC decrease mask increased and the proportion of voxels 
connected from outside to inside decreased. Strong correlations were observed between all these indices 
and the initial DC decrease findings (mean connectivity: r=0.81; p<0.001, proportion of connected 
voxels: r=0.84; p<0.001, shift in connectivity: r=-0.85; p<0.001; N=394) (fig. S3). As the shift in 
connectivity showed the strongest correlation with the initial DC findings, this hypo-connectivity index 
was selected for further testing of associations with clinical symptoms. 
The further exploration in the EU-AIMS LEAP dataset of the choice of correlational threshold for DC 
computation on the observed differentiation between ASD and TD revealed a maximum differentiation 
for the hyper- and hypo-connectivity index at r=0.15 and r=0.4, respectively (Fig 2C). For both indices 
the effect size for differentiation between ASD and TD obtained at the initially chosen DC threshold 
(r=0.25) recommended by the literature (26) was very close to the maximum observed with those 
optimized thresholds. These results support the use of the recommended threshold for DC-based 
analyses of the ASD population. 
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To better understand the spatial specificity of the observed shifts from outside to inside the respective 
DC masks for both hyper- and hypo-connectivity indices we have additionally recomputed both indices 
by splitting the outside regions into cortical, subcortical or cerebellar regions of interest. Only the 
cortico-cortical shifts in connectivity revealed significant (p<0.001) and numerically larger effect sizes 
for differentiation between ASD and TD than the initial whole-brain hyper- and hypo-connectivity 
indices (Table 3). No significant differences were observed for both indices when using subcortical and 
cerebellar outside regions, with effect sizes close to zero (Table 3). 
Connectivity differences are linked to demographic and clinical factors 
We next evaluated if and how these hyper- and hypo-connectivity indices relate to clinical 
characteristics, age, sex, medication and psychiatric comorbidity status in individuals with ASD. First,  
we used t-tests to evaluate if the hyper- and hypo-connectivity alterations persisted when splitting the 
cohorts into children, adolescents and adults. As InFoR only comprised adults, these analyses were 
restricted to the other cohorts. For the hyper-connectivity index, significant differences and similar 
effect sizes were observed for all age groups in the EU-AIMS LEAP cohort (all p<0.001, Fig 3A). In 
other cohorts significant differences between individuals with ASD and TD were observed for 
adolescents (ABIDE I only, p=0.028) and adults (ABIDE I: p=0.014, ABIDE II: p=0.015) but not for 
children (Fig 3A). The hypo-connectivity index showed consistently larger effect sizes in the adolescent 
and adult populations as compared to children in all three cohorts (Fig 3B). In formal testing for age 
category by diagnosis interactions on the hyper- and hypo-connectivity indices using analysis of 
variance (ANOVA) no significant interactions were observed (table S2). 
In ANOVA testing for the effects of sex on the observed hyper- and hypo-connectivity indices no 
significant sex-by-diagnosis group interactions were observed for any of the cohorts (all p>0.1)(table 
S2). A significant effect of psychotropic medication on functional connectivity was only found for DC 
increases in the EU-AIMS LEAP cohort with individuals with ASD on medication being closer to the 
TD population (table S3). Psychiatric comorbidity status was only available for a subsample of the 
ABIDE II cohort. There was no significant difference between ASD with and without comorbidity 
diagnoses with respect to DC increases (t(187)=0.1;p=0.903), decreases (t(187)=-1.0;p=0.335) or 
derived hyper- (t(187)=0.6;p=0.582) and hypo-connectivity (t(187)=1.5;p=0.147) indices (fig. S4). 
Psychiatric comorbidity and medication status were only weakly associated in that sample (Kendall’s 
tau=0.18;p=0.014) (table S4). 
Following a similar exploration and replication strategy as for group comparisons, twelve general linear 
models were computed in the EU-AIMS LEAP dataset to evaluate if the obtained hyper- and hypo-
connectivity indices are linked to clinical severity (table S5). These analyses revealed overall two 
significant relationships between the hyper-connectivity index and Autism Diagnostic Interview (ADI) 
communication subscale (p=0.026) and Vineland Adaptive Behavior Scale (VABS, (27)) daily living 
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skills standard score (p=0.024) (Table 4 and table S5). Stronger connectivity alterations were associated 
with stronger clinical impairment (Fig 3C). In replication analyses, both relationships found in EU-
AIMS LEAP were also significant in the ABIDE I cohort (ADI communication: p=0.004, VABS daily 
living skills: p=0.048) but not in the substantially younger ABIDE II subset (Table 4, table S6). In an 
additional exploratory analysis of the EU-AIMS LEAP cohort we examined the correlational structure 
between the identified ADI communication subscale and the VABS subscales. This analysis was 
performed to better understand why VABS daily living skills (but not the corresponding communication 
subdomain) were associated with the hyper-connectivity index. ADI communication subscale was 
numerically more strongly associated with VABS daily living skills (r=-.29;p=0.006) than with the 
VABS communication (r=-.24;p=0.029) subdomain (Fig 3D). 
Understanding relationship to underlying structure 
Lastly, we aimed to evaluate if the observed DC alterations or the extracted ASD hyper- and hypo-
connectivity indices were related to underlying grey matter structure or to previously reported white 
matter alterations (whole cerebral white matter and corpus callosum subregions) (28). For this, we first 
compared the respective volumetric information between ASD and TD and then correlated the 
respective structural information with the identified functional connectivity alterations. Overall white 
(p=0.017) and splenium of corpus callosum matter (p=0.014) were reduced in ASD displaying yet small 
effect sizes (table S7). Grey matter volume in the selected regions and genu and body of corpus callosum 
were not significantly different between ASD and TD. Only white matter in genu of corpus callosum 
but none of the other structural information was significantly correlated with the DC increase values 
(r=-0.1;p=0.043) and the respective ASD hyper-connectivity index (r=0.1;p=0.04) with lower genu 
volume being associated with stronger rs-fMRI alterations (table S8). 
Discussion 
Here we provide evidence of reproducible functional hyper- and hypo-connectivity alterations in 
individuals with ASD as demonstrated across several large single- and multi-center cohorts. We further 
show that these alterations persisted when controlling for motion and medication effects and were linked 
to clinical symptoms as captured by several clinical and behavioral scales. 
We reconcile previous divergent literature findings and report evidence of both functional hypo- and 
hyper-connectivity in individuals with ASD, with spatially-varying signatures that are consistent with 
some of the recent single cohort evidence(10, 12, 19, 20). The identified hypo- and hyper-connectivity 
patterns that are based on a positive correlation threshold show spatial similarity across all cohorts with 
the hypo-connectivity being primarily restricted to sensory-motor regions and hyper-connectivity hubs 
being predominately located in prefrontal and parietal cortices. Both anatomical networks are consistent 
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with some previous work reporting connectivity alterations in respective networks(10, 21, 29). 
Moreover, our results suggest that the identified alterations are primarily driven by cortico-cortical 
connectivity shifts with little to no cerebellar or subcortical contribution. These findings contrast with 
some of the previous literature suggesting alterations in cerebro-cerebellar and cerebro-subcortical 
connectivity as a key alteration in ASD(30, 31). Substantial differences in preprocessing and 
methodology may account for some of these discrepancies. Consistent with some previous reports, we 
find the overall global connectivity to be preserved in ASD(21). 
Anatomically, the DC increase regions closely correspond to the well-established central executive 
network(32–34). This network has been closely implicated in high-level cognitive functions such as 
planning, decision making, and the control of attention and working memory(33). All of these functions 
have been consistently shown to be affected in ASD(35–37). Moreover, we demonstrate that the DC 
increases originate specifically from increased engagement of this network by regions outside the 
network. Similarly, DC decreases are mainly driven by disengagement of the sensory-motor network 
from other regions. However, we also observe a similar magnitude of reduced connectivity within the 
sensory-motor network suggesting that both processes contribute to DC decreases. Biologically, these 
connectivity shifts may support the idea that individuals with ASD are unable to engage or disengage 
specific networks to the extent of TD, and may therefore underlie deficits in mental switching and 
cognitive flexibility(35, 36).  
Estimates of effect size range from small to very large across cohorts. The ABIDE I and II datasets are 
retrospectively established cohorts with large variation in diagnostic and inclusion criteria, sequence 
quality, scanning duration and other parameters such as resting state acquisition instructions. This 
variability may explain the observed low effect sizes. In contrast, the standardized multi-center EU-
AIMS LEAP and the single center InFoR cohort show a large effect size for the hyper-connectivity and 
a moderate to large effect size for the hypo-connectivity alterations, suggesting that these measures may 
indeed have promise as stratification or treatment biomarkers for ASD. Whilst these results provide a 
valuable first step demonstrating the existence of a consistent functional connectivity phenotype 
associated with ASD they also at the current stage point to the limited usability of the respective 
alterations as a diagnostic biomarker considering the large overlap between ASD and TD. As a key 
focus of our study primarily in identification and replication of the respective alteration, a large amount 
of possible optimizations remains to be explored including deployment of improved sequences but also 
evaluation of other than default processing parameters and further spatial dissection of respective 
alterations. All of these aspects may result in further increases in effect size potentially lifting it to a 
clinically relevant magnitude. 
The above results contribute to a growing consensus on the specific networks characterized by hyper- 
vs. hypo-connectivity profiles in ASD, but also extend this work to demonstrate a key driver of ASD's 
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connectivity profile: the larger proportion of frontoparietal voxels within our "DC Increase" mask 
showing suprathreshold connectivity with voxels outside this mask, and the larger proportion of 
somatosensory voxels within our "DC Decrease" mask showing subthreshold connectivity with voxels 
outside this mask. Our somatosensory findings especially concord with emerging ICA-based analyses 
of the EU-AIMS LEAP and other cohorts (38) , in which connectivity alterations in ASD are generally 
most pronounced when considering connectivity between networks. This concordance, despite different 
preprocessing and analysis methodologies, suggests ample robustness to the results reported here, and 
motivate further characterization of the etiology, development and clinical symptoms associated with 
these phenotypes in ASD. At the same time, we note that the most consistent ICA-based findings of 
between-network differences involve cerebellum, which was only inconsistently acquired in the broader 
range of cohorts analyzed here. Clearly, the role of cerebellar function in the broader ASD phenotype, 
and its relation to frontoparietal connectivity in particular, may be an important direction for future 
work(39). We do not find consistent age-by-diagnosis interactions on the identified hyper- and hypo-
connectivity indices. Nonetheless, numerically all cohorts show smaller effect size for the hypo-
connectivity index in children suggesting a potential increase of these alterations over age. As this index 
is not associated with any clinical scales, it may serve a more compensatory role that increases with 
age. In line with this hypothesis, previous studies reported age-related improvement among older 
individuals with ASD in terms of cognitive flexibility(40). The absence of the functional connectivity 
alterations in two out of the three children cohorts may also point to a potentially secondary role of the 
respective alterations, for example emerging due to prolonged social interaction. However, also other 
possible explanations such as differential neurodevelopmental trajectories or long term exposure to 
medication are also possible.  Prospective longitudinal studies are therefore essential to further dissect 
the role of the identified functional connectivity alterations in ASD.  
In line with the idea of differential neurodevelopmental trajectories, a previous large diffusion tensor 
imaging study in toddlers with ASD demonstrated alterations in axon pathways connecting primarily 
prefrontal and other brain regions(41) and these findings are also supported by an earlier postmortem 
study in ASD reporting altered white matter composition below prefrontal regions (42). The respective 
imaging study did not find any alterations in white mater connections in parietal regions. In line with 
that, the visualization of voxel-wise degree centrality provided in our study illustrates a more dominant 
prefrontal pattern in both ABIDE cohorts whilst the parietal effects are primarily observed in both EU-
AIMS and the adult only InFoR cohort. This discrepancy may point to the rather later emergence of the 
parietal alterations and also to some extent explain the low effect size in the younger ABIDE II cohort 
when extracting the signal from the whole fronto-parietal network identified in the EU-AIMS LEAP 
dataset. Supportively, the only associations between structural and functional information identified in 
our study was the correlation of fronto-parietal DC and the respective hyper-connectivity index with 
white matter in genu of corpus callosum connecting specifically prefrontal regions to each other. The 
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directionality of these correlations points to larger alterations in both resting state measures being 
associated with lower genu volume. However, the rather weak nature of this association combined with 
the much lower effect size for the white matter alterations also point to a largely independent 
contribution of both endophenotypes with stronger relevance of the identified functional connectivity 
alterations going beyond changes in underlying structure. Our results also support the idea of an altered 
topology in ASD with a spatially distinct pattern of between network connections with both hyper- and 
hypo-connectivity being present(43). 
When evaluating the link between imaging and clinical features, we find that the extent of hyper-
connectivity abnormalities is correlated with autism symptoms in two out of three cohorts. Hyper-
connectivity was associated with ADI communication functioning as well as VABS daily living skills 
but not the respective VABS communication subscale. Greater connectivity alterations are thereby 
associated with greater severity of respective symptoms. Additional exploratory analyses illustrated the 
rather weak relationship between deficits captured by the corresponding ADI and VABS subscales 
suggesting that VABS daily living skills are more closely correlated with ADI communication scores. 
A potential reason for this closer link to VABS daily living skills may be due to ADI collecting 
information about ASD-specific communication deficits historically observed in daily living rather than 
differentiating these subdomains in terms of current functioning, as assessed by the VABS. These 
findings further support the idea that these alterations may reflect pathological processes related to skills 
needed for development of personal independence and social communication abilities. We also failed 
to replicate this association in the on average six to ten years younger ABIDE II subpopulation. 
Considering that ABIDE II children diagnosed with ASD do not show any detectable connectivity 
abnormalities, the lack of significant correlation with clinical symptoms in this cohort is not surprising. 
Overall, further research is needed to understand the specific reasons for these discrepant findings. 
Potential confounding effects of medication on functional connectivity have been raised for previous 
ASD studies(24). Here, we did not find consistent effects of psychotropic medication on the functional 
connectivity measures with the only effect pointing to reduced functional connectivity alterations with 
psychotropic medication use. On one side, the rather low effect size of those associations limits their 
immediate usability as potential surrogate efficacy read-outs. On the other side, the large effect size in 
the standardized cohorts, the link to the clinical symptoms and, if replicated, the preliminary evidence 
in one of the cohorts that ASD medication may move the networks closer to TD warrant further 
exploration of these alterations as a potentially more sensitive and earlier pharmacodynamic read-out 
for treatment evaluation. Similarly, in the only cohort (ABIDE II) where psychiatric comorbidity status 
was consistently provided, we did not find any evidence of its impact on the observed functional 
connectivity alterations. Although these results are consistent with the notion that the observed imaging 
alterations are specific to ASD, further analysis of broader cohorts are needed to fully address the 
question of specificity. 
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For statistical and data quality reasons we have excluded for all analyses data of individuals with ASD 
with low IQ or where imaging quality including excessive motion did not meet prespecified criteria. 
More specifically, motion is critically discussed in the literature as a potential contributor or even driver 
of functional connectivity alterations observed in previous studies(44, 45).  Similarly, low IQ is often 
associated with specific factors such as genetic etiologies or prenatal events including exposure to 
specific drugs(46–49). Those factors are likely to increase variability of the overall population 
potentially reducing the sensitivity to detect specific between group differences. Additionally, the low 
prevalence of low IQ subjects was not equally distributed across cohorts and between ASD and TD in 
the EU-AIMS dataset inducing an additional statistical bias which we aimed to avoid. It was therefore 
critical for interpretation of our findings to minimize any possible confounding effects associated with 
both factors by excluding these subjects. Nonetheless, whilst these exclusion criteria are important to 
enable more clear interpretation of the outcomes, they also limit the generalizability of our findings to 
the excluded patient populations. In addition, also the role of other potential confounding factors such 
as presence of specific neurological conditions or congenital malformations may have contributed to 
observed differences and needs to be explored in future studies collecting detailed information on the 
respective aspects. 
Lastly, we did not used the INFOR dataset for replication of the clinical associations; considering the 
rather weak nature of the observed associations in the EU-AIMS LEAP cohort, the InFoR dataset did 
not provide sufficient power (only 12% power based on power-analysis using G-Power) to detect the 
respective associations. 
In conclusion, we provide evidence of reproducible hyper- and hypo-connectivity alterations in 
individuals with ASD. These alterations are mainly driven by shifts in connectivity from within to 
outside the respective networks and are partially associated with core clinical deficits observed in ASD. 
Materials and methods 
Study design 
The primary objective of the study was to identify and independently replicate rs-fMRI-based functional 
connectivity alterations associated with ASD as compared to TD. Further, we aimed to understand the 
specific nature of these alterations and if they are associated with methodological, demographic or 
clinical factors known to affect rs-fMRI derived measures. Lastly, we explored if these functional 
connectivity alterations are linked to core clinical symptoms observed in ASD. To enable an accurate 
identification and replication of functional connectivity alterations in ASD four cross-sectional datasets 
were included into the study (Table 1, Supplementary materials and methods, table S9-11): EU-AIMS 
LEAP (www.eu-aims.com), ABIDE I, ABIDE II and InFoR (10, 50–52). All cohorts acquired rs-fMRI 
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data (Supplementary materials and methods, table S12-15) in individuals with ASD and TD along with 
other cohort-specific measures. Only individuals with ASD with average range IQ (>70) were included 
for further analyses to reduce variability associated with low functioning ASD (53). A further statistical 
reason for exclusion of this population was in the strong imbalance in the EU-AIMS dataset with more 
than twice as many individuals with ASD meeting this criterion as compared to TD. Additionally, only 
few subjects meeting this criterion were available in all replication cohorts. In brief, EU-AIMS LEAP 
cohort is a large well characterized multicenter cohort of individuals with ASD and TD. EU-AIMS 
LEAP recruitment was performed using existing local databases, clinic contacts, and local and national 
support groups. TD were recruited via mainstream schools, flyers, and existing databases. A BIDE I 
and II provide large, retrospectively aggregated multi-center data with varying diagnostic and 
recruitment criteria, rs-fMRI sequences and clinic scales. InFoR is a smaller single center cohort with 
standardized imaging assessments. As the only large cohort with standardized imaging assessments and 
inclusion/exclusion criteria, the EU-AIMS LEAP dataset was selected for exploratory analyses. The 
three other cohorts were used for replication of the identified functional connectivity alterations. All 
studies were approved by local ethics committees. Further details on rs-fMRI data collection and pre-
processing are provided in Supplementary materials and methods. 
Statistical analyses 
Identifying functional connectivity alterations 
Given the divergent prior findings on functional connectivity alterations in ASD, we followed an 
unbiased exploratory approach by computing a simple connectivity metric (degree centrality – DC, 
(56)) to compare individuals with ASD and TD. DC is a count-based measure that assigns to each voxel 
the sum of all correlation coefficients between the time series of that voxel and all other voxels in the 
brain exceeding a prespecified threshold (r>0.25) (26). Only positive correlations were included to 
avoid spurious negative correlations that may arise from global signal regression (58). This threshold 
was recommended in previous studies using DC to eliminate counting voxels that had low temporal 
correlation attributable to signal noise (26). All further group comparison and correlational analyses 
were controlled for site, sex, age and IQ effects. As compared to many other connectivity approaches 
proposed in the literature DC does not require specific assumptions about the location of the signal and 
can be computed on a voxel-wise basis. Though dimensionality reduction techniques such as 
independent component analysis are also often applied in the literature to evaluate functional 
connectivity, they are less optimal for the key focus of our study which was in replication across 
different cohorts. Solutions provided by such algorithms are often highly susceptible to differences 
across study populations such as sample size, demographics and scanner and sequence differences. Also 
there is no consistent approach for matching the identified components across cohorts. The DC 
approach was therefore chosen for the replication focus of this study.  
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The resulting DC maps for EU-AIMS were entered into a voxel-wise general linear model (GLM) 
comparing individuals with ASD and TD. A liberal voxel-wise uncorrected threshold of p < 0.05 
combined with an exact permutation based (1000 permutations) family-wise error corrected cluster 
threshold of p < 0.05 was used in those analyses to test for significance (59). All analyses were 
controlled for site, sex, age and IQ effects. Identical GLM designs were then created for ABIDE I, 
ABIDE II and InFoR data. Weighted mean DC signals (first eigenvariate) were extracted for the three 
replication cohorts based on EU-AIMS LEAP findings. Effect sizes (Cohen’s d) and independent 
sample t-tests were computed comparing DC values between individuals with ASD and TD (p<.05). 
We then tested if the whole-brain DC alteration patterns observed in ASD are similar across the cohorts 
by computing correlations between the un-thresholded t-maps (degrees of freedom for p-value 
computation are based on number of resolution elements in the images provided by SPM12) (Figure 
1C, D). As residual motion effects have been repeatedly criticized as potential sources of observed 
functional connectivity differences between ASD and TD (54), we have computed mean translational 
and rotational motion and frame-wise displacement and compared it between ASD and TD using t-tests 
(table S1). As the mean frame-wise displacement was indeed significantly higher in ASD as compared 
to TD, we have also recomputed all analyses by additionally controlling for the effects of the motion 
parameters in the between group comparison. For this we added mean translational and rotational 
motion and mean translational and rotational frame-wise displacement for each subject as additional 
covariates of no interest and recomputed the above analyses. 
Understanding the nature of functional connectivity alterations 
Whilst DC provides evidence of altered functional connectivity, it does not allow conclusions on the 
nature of those alterations. For example, DC changes could arise from alterations in mean strength 
and/or variance of the underlying connectivity, or shifts in connectivity from within to outside of the 
respective networks. To better understand the observed functional connectivity alterations, we first 
computed subject-specific pair-wise correlations between time courses of all voxels in the brain. Based 
on these correlations we computed the following four types of connectivity indices within and outside 
regions showing DC alterations as defined in figure S2: 1) mean connectivity of all voxels (Fisher’s z-
transformed), 2) variance of connectivity of all voxel-wise correlations (Fisher’s z-transformed) 3) 
proportion of connected voxels, and 4) shifts in connectivity from inside to outside the respective 
regions. 
Effect sizes and t-tests comparing individuals with ASD and TD were then computed for each of the 
above indices. To test if these indices indeed reflect the initial DC changes we computed correlations 
between both in the EU-AIMS LEAP dataset. Indices showing strongest correlation with initial DC 
increase and decrease findings and a similar or higher effect size were selected for further evaluations. 
These two indices providing a more refined view on functional connectivity alterations were extracted 
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for the three replication cohorts and used for further analyses. Both indices are further referred to as 
hyper- and hypo-connectivity indices.  
We further examined in how far the initial choice of the correlational threshold used for DC computation 
affected the effect sizes observed with both indices. For this, we systematically varied in the EU-AIMS 
LEAP dataset the correlational threshold from -0.25 to 0.7 computing the effect sizes for differentiation 
between ASD and TD. 
Lastly, as previous studies reported potential differences in between network connectivity alterations in 
cortical, subcortical and cerebellar regions we have additionally computed the effect sizes and t-tests 
comparing ASD and TD for the above two indices by re-computing them using for outside regions 
either cortical, subcortical or cerebellar masks as described in Supplementary methods (30, 31). 
Evaluation of cortical, subcortical and cerebellar hyper- and hypo-connectivity indices 
To re-compute the identified hyper- and hypo-connectivity indices splitting the outside regions into 
cortical, subcortical and cerebellar subregions we masked the outside regions (outside the respective 
DC increase and decrease masks) using the Automated Anatomical Labeling – AAL atlas. Thereby, an 
inclusive mask was computed between the outside DC masks and a cortical mask pooling all cortical 
AAL regions. Similarly, an inclusive mask was computed between the DC outside masks and 
subcortical regions pooling caudate, putamen and thalamic AAL regions. For cerebellum mask, all AAL 
cerebellum and vermis regions were used. The hyper- and hypo-connectivity indices as defined in 
equation π5 in Figure 2 of the main manuscript were recomputed for the obtained cortical, subcortical 
and cerebellar masks. 
Understanding the link between imaging findings and clinical and demographic factors 
Having identified the hyper- and hypo-connectivity indices as replicable ASD biomarkers we next 
investigated their relationship to clinical symptoms, medication status, age and sex. To test for 
differential effects of age, we split the cohorts into three age categories: children (below 12), adolescents 
(age between 12 and 18) and adults (age above 18). Hyper- and hypo-connectivity indices between 
ASD patient and respective TD populations were compared by computing effect sizes and t-tests 
(controlling for overall age effects, sex, site and IQ). As based on the outcomes of the overall cohort we 
had clear directionality hypotheses a one-sided p<0.05 was applied. Additionally, we formally tested 
for age-by-diagnosis interactions (three age categories) using ANOVAs controlling for sex, site and IQ. 
Similarly, to test for the effects of sex we computed ANOVAs testing for sex-by-diagnosis interactions 
controlling for age, site and IQ. We further evaluated for each cohort if psychotropic medication 
interferes with the observed functional connectivity alterations. Because detailed medication 
information on specific drugs, dose or duration was not available we restricted the analyses to t-tests 
Holiga et al. 
comparing DC and hyper- and hypo-connectivity indices between patients on and off psychotropic 
medication. Additionally, we aimed to evaluate whether psychiatric comorbidity and concomitant 
medication status might also contribute to the observed functional connectivity alterations. For a 
subcohort of ABIDE II the psychiatric comorbidity status was also available (N=189, 72 with 
comorbidities). For this subcohort, we computed t-tests comparing the obtained DC and respective 
hyper- and hypo-connectivity indices (adjusted for age, sex, site and IQ) and explored the relationship 
between medication and comorbidity status using Kendall’s tau. 
To test for potential relationships between hyper- and hypo-connectivity indices and clinical scales, we 
followed a similar exploration and replication strategy as for the group comparisons. Because of few 
overlaps regarding clinical scales and a much smaller number of patients than in the exploration sample 
InFoR was not used for these analyses. Separate GLMs (as implemented in SPSS) were computed using 
the hyper- and hypo-connectivity indices to predict clinical severity in the EU-AIMS LEAP individuals 
with ASD (table S6). Significant (p<0.05, two-sided) relationships identified in the EU-AIMS cohort 
were selected for replication in ABIDE I and II using identical GLMs. Additionally, we explored the 
interrelationship of the ADI and VABS subscales showing a significant association with the hyper- and 
hypo-connectivity indices in the EU-AIMS LEAP dataset by computing Pearson correlations among 
the respective measures. 
Understanding relationship to underlying structure 
Lastly, we aimed to evaluate if the observed functional connectivity alterations are related to potential 
underlying grey matter structural changes, as between-group structural differences may confound the 
effects seen on functional connectivity  (60). To address this question, two-types of analyses were 
performed using eigenvariates of grey matter volumes extracted using both DC masks and adjusted for 
age, sex, site, IQ and total intracranial volume: 1) group comparisons of ASD and TD using two-sample 
t-tests, and 2) Pearson correlations between grey matter volumes and respective DC and hyper- and 
hypo-connectivity indices.  Additionally, as previous studies have reported reduced white matter and 
specifically corpus callosum volumes in ASD, we repeated both types of analyses using white matter 
volumes extracted from the respective regions using the Jülich white matter atlas (whole white matter, 
corpus callosum, genum, body and splenium) (28, 61). 
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Table 1 Clinical and demographic characteristics 
  
EU-AIMS LEAP ABIDE I ABIDE II InFoR 
  
ASD TD 
Stats 
(test 
value,  
df, p-
value) ASD TD 
Stats 
(test 
value,  
df, p-
value) ASD TD 
Stats 
(test 
value,  
df, p-
value) ASD TD 
Stats 
(test 
value,  
df, p-
value) 
N 202 192 - 299 376 - 306 391 - 34 25 - 
Male/female 142/60 
124/6
8 
1.5,1,.2
26 
268/31 
313/6
3 
5.7,1,.0
17 
262/44 
263/1
27 
30.4,1
,<.001 
26/8 
19/
6 
0.0,1,.
967 
Age±SD 
17.5±5.
3 
17.4±
5.7 
0.1,392
,.915 
17.5±7
.7 
17.7±
7.8 
-
.3,673,.
776 
14.0±6.
8 
13.6±
6.2 
.8,695
,.428 
29.5±8.
9 
30.
6±8
.3 
.5,57,.
638 
Child/Adol/Adult 
35/76/9
1 
43/71
/78 
1.7,2,.4
34 
69/118
/112 
85/14
7/144 
.1,2,.97
4 
147/85/
74 
234/7
7/80 
10.3,2
,.006 
0/0/34 
0/0/
25 
- 
IQ (mean±SD, N) 
106±14
.9 
109±1
2.6 
-
2.1,392
,.033 
106.3±
16.0 
112.0
±12.1 
-
5.3,673
,<.001 
107.0±
16.0 
115.7
±12.5 
-
8.0,69
5,<.00
1 
104.3±
18.7 
108
.6±
17.
5 
.9,54,.
392 
DSM IV diag (none/ ASD/ 
Asperger/ PDD-NOS) 
- - - 
16/204
/60/16 
- - 
121/55/
78/52 
- - - - - 
On medication (N) 54 2 - 61 1 - 81 17 - - - - 
ADOS total (mean±SD, N) 
10.1±4.
9, 170 
- - 
11.9±3
.7,259 
1.3±1
.4,30 
15.4,28
7,<.001 
10±3.7,
167 
1.8±1
.7,38 
13.4,2
03,<.0
01 
- - - 
ADI social (mean±SD, N) 
15.7±6.
7,191 
- - 
19.9±5
.4,184 
-  - 
18.7±5.
8,217 
- - 
16.2±6.
4,25 
- - 
ADI communication 
(mean±SD, N) 
12.9±5.
8, 191 
- - 
15.8±4
.7,185 
-  - 
14.9±4.
6,217 
- - 
9.4±5.3
,25 
- - 
ADI RRB (mean±SD, N) 
4.1±2.6
,191 
- - 
6.1±2.
5,185 
-  - 
5.5±2.5
,217 
- - 
2.2±1.3
,22 
- - 
SRS t-score 
68.9±1
1.9,165 
45.9±
7.5,90 
16.6,25
3,<.001 
- - - 
75.4±1
3.5,256 
- - - - - 
VABS adaptive behavior 
composite (mean±SD, N) 
70.0±1
2.3,87 
- - 
77.3±1
3.7,60 
- - 
82.8±1
0.9,61 
- - - - - 
VABS daily living skills 
(mean±SD, N) 
71.0±1
3.5,87 
- - 
83.2±1
5.2,60 
- - 
87.4±1
0.4,61 
- - - - - 
VABS socialization 
(mean±SD, N) 
69.3±1
6.6,88 
- - 
75.0±1
6.5,60 
- - 
82.5±1
2.5,61 
- - - - - 
VABS communication 
(mean±SD, N) 
77.3±1
4.9,88 
- - 
79.3±1
5.5,60 
- - 
87.3±1
3.9,61 
- - - - - 
ADI – Autism Diagnostic Interview, ADOS – Autism Diagnostic Observation Schedule, ASD – Autism 
spectrum disorder patients, PDD-NOS – Pervasive developmental disorder not otherwise specified, 
RRB – Restricted and repetitive behaviors, SD – Standard deviation, SRS – Social Responsiveness 
Scale, TD – Typically developing controls 
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Table 2. Regions showing significant DC differences in the EU-AIMS LEAP cohort between 
individuals with ASD and TD 
Contrast Anatomical region Cluster size 
Exact 
cluster p-
value 
T-value MNI coordinates 
ASD > TD 
Bilateral: Parietal, posterior 
cingulate, precuneus, primary 
visual 
3066 0.008 5.35* -33 54 39 
ASD > TD 
Bilateral: Lateral and medial 
prefrontal, premotor, 
supplementary motor, anterior 
cingulate 
4851 0.001 5.33* 36 42 3 
Right: Anterior insula, caudate 
TD > ASD 
Bilateral: Primary sensory, 
primary motor, middle cingulate 
5777 <.001 5.41* 12 -33 69 
Right: Posterior insula, temporal cortex, 
amygdala, hippocampus, entorhinal 
* Significant at a whole-brain voxel-wise family-wise error corrected threshold of p<.05 
 
Table 3. Effect sizes and p-values for the hyper- and hypo-connectivity indices computed using 
cortical, subcortical and cerebellar subregions comparing ASD and TD 
"Outside" region 
Hyper-connectivity  
index 
(Cohen’s d;p) 
Hypo-connectivity  
index 
(Cohen’s d;p) 
Cerebellar -0.12;.233 0.05;.619 
Cortical -0.76;<.001 0.46;<.001 
Subcortical 0.05;.604 -0.10;.332 
ASD – Autism spectrum disorder, TD – typically developing controls 
Table 4 Results of correlations between hyper- and hypo-connectivity indices and clinical scales  
Scale 
Connectivity 
measure 
EU-AIMS LEAP ABIDE I ABIDE II 
ADI communication total hyper-conn F(1,182)=5; p=0.026 F(1,171)=8.7; p=0.004 F(1,204)=0.3; p=0.602 
VABS daily living standard hyper-conn F(1,80)=5.3; p=0.024 F(1,55)=4.1; p=0.048 F(1,55)=0.1; p=0.75 
ADI – Autism Diagnostic Interview, ASD – Autism spectrum disorder, DC – Degree centrality, conn – 
connectivity index, VABS – Vineland Adaptive Behavior Scales, Significant (p<0.05) relationships 
between functional connectivity indices and respective clinical scales are indicated in bold. 
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Figure 1. Outcomes of functional connectivity comparisons between individuals with ASD and TD. (A) 
Representative reconstruction of a brain illustrating regions showing significant DC increases (red) and decreases 
(blue) in individuals with ASD in the reference EU-AIMS LEAP cohort. (B) Distribution of DC values (first 
eigenvariate over the masks’ voxels) across subjects for the hyper-connected (top row, red) and hypo-connected 
(bottom row, blue) network separately for individuals with ASD and TD. (C) Unthresholded t-maps showing 
regions with increased (warm colors) and decreased (cold colors) DC in individuals with ASD as compared to 
TD. (D) Spatial correspondence of the t-maps between the reference data set (EU-AIMS LEAP) and all remaining 
replication data sets (ABIDE I, ABIDE II, InFoR) in form of a pair-wise correlation matrix and individual 
correlation plots. A – anterior, ASD – autism spectrum disorder, d – Cohen’s d effect size, DC – degree centrality, 
FWE – family-wise error, L – left, P – posterior, R – right, TD – typically developing. *p < 0.05, **p < 0.01, ***p 
< 0.001 as obtained using independent samples t-tests (b) and Pearson correlation analyses (d). 
Figure 2. Functional connectivity indices and their effect size (A) Distribution of the Pearson correlation 
coefficients between pairs of voxel-wise blood oxygen level dependence (BOLD) activity time courses observed 
in ASD and TD in the EU-AIMS LEAP cohort. (B) Effect sizes of the functional connectivity indices based on 
DC masks for the contrasts ASD > TD (left) and TD > ASD (right). Indices: mean connectivity (µ), variance of 
connectivity (σ) and proportion of connected voxels (π) within (1), outside (2), and from within to outside (3) the 
DC alteration masks and shifts in connectivity from within to outside (π4) and from outside to within (π5) the DC 
alteration mask. Details on computation are provided in figure S3. ASD – autism spectrum disorder, DC – degree 
centrality, o – outside, r – correlation coefficient, rz – Fisher’s z-transformed correlation coefficient, TD – 
Typically developing, w – within, prop – proportion, Std – standard deviation. *p < 0.05, **p < 0.01, ***p < 
0.001 as obtained using independent samples t-tests, - – indicates the original negative sign of the respective index. 
(C) Effect size for the hyper- and hypo-connectivity indices obtained in the EU-AIMS LEAP dataset plotted versus 
the applied correlational threshold. Dashed line indicates the correlational threshold used for the initial degree 
centrality computation 
Figure 3. Relationships between hyper- and hypo-connectivity indices, age and clinical outcomes. (A) 
Effect size of the hyper-connectivity index for all patients and split by age groups (children [<12 years], 
adolescents [12–18 years], adults [>18 years]) for contrast ASD > TD (red). (B) The equivalent of (a) for the 
hypo-connectivity index (blue). (C) Correlations of the hyper-connectivity indices with ASD clinical scales in 
the EU-AIMS LEAP and ABIDE I data sets (adjusted for the effects of age, sex, site and IQ). (D) Correlations 
between ADI communication and VABS daily living skills and communication subscales, ADI – Autism 
Diagnostic Interview, VABS – Vineland Adaptive Behavior Scale, ASD – autism spectrum disorder, comm – 
communication, dls – daily living skills, *p < 0.05, **p < 0.01, ***p < 0.001 as obtained using independent 
samples t-tests. 
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